Efficacy of fibrin sealant in reducing resection surface crelated complications after partial liver resections

Completed

• Conditions: Partial liver resection complications; Surgery; Liver resection

• Registration Number: ISRCTN85205641
• Lead Sponsor: Johnson and Johnson Medical Limited (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-05-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

1. Patients aged greater than or equal to 18 years, either sex
2. Undergo liver resections (at least one segment) for benign or malignant tumours or metastatic tumours, or
3. Undergo liver resection in combination with radiofrequency ablation (RFA)

Exclusion Criteria

1. Aged less than 18 years
2. Undergo liver resections with extrahepatic biliary resection and reconstruction (Klatskin tumours)
3. Cirrhosis
4. Other disorders of haemostasis
5. Polycystic liver disease
6. Any associated operative gastrointestinal procedures (a needle catheter jejunostomy is not excluded)
7. Wedge resections
8. Pregnancy
9. History of hypersensitivity, allergy or anaphylactic reaction to any plasma derived product, including fibrin sealant

Study & Design

• Study Type: Interventional
• Study Design: Not specified